GLOBUS MEDICAL, INC. Share Repurchase Authorization
GLOBUS MEDICAL, INC. (GMED) had Share Repurchase Authorization of $200.00 million as of 2020-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2023-08-03
- 2020-03-31: Stock Repurchase Program, Authorized Amount $200.00M.
- 2020-03-11: Stock Repurchase Program, Authorized Amount $200.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2020-03-31 | $200.00M 10-Q · filed 2022-05-10 |
| 2020-03-11 | $200.00M 10-Q · filed 2023-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |